Cart
sales@molnova.com
ODM-207
CAS No. 1801503-93-4
ODM-207( BET-IN-4 | ODM-207 | ODM207 )
Catalog No. M26070 CAS No. 1801503-93-4
BET-IN-4 is a potent BRD4 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 84 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 249 | In Stock |
|
| 50MG | 351 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 682 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameODM-207
-
NoteResearch use only, not for human use.
-
Brief DescriptionBET-IN-4 is a potent BRD4 inhibitor.
-
DescriptionBET-IN-4 is a potent BRD4 inhibitor.(In Vitro):BET-IN-4 inhibits BRD4 with an IC50 of ≤ 1 μM.
-
In VitroODM-207 (Compound 50) is a potent BET bromodomain protein (BRD4) inhibitor, with an IC50 of ≤ 1 μM.
-
In Vivo——
-
SynonymsBET-IN-4 | ODM-207 | ODM207
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801503-93-4
-
Formula Weight375.428
-
Molecular FormulaC22H21N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (26.64 mM)
-
SMILESCOc1cc2n(Cc3ccccn3)c(=O)c(C)cc2cc1-c1c(C)noc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kao-Lu Pan, et al. Identification of trans,trans-2,4-decadienal metabolites in mouse and human cells using liquid chromatography-mass spectrometry. Chem Res Toxicol. 2014 Oct 20;27(10):1707-19.
molnova catalog
related products
-
BRM/BRG1 ATP Inhibit...
BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
-
ZEN-3411
ZEN-3411 is an orally available and potent BET inhibitor that inhibits BRD4(BD1), BRD4(BD2), and BRD4(BD1BD2) and suppresses the growth of tumor cells overproducing BET proteins.
-
Menin-MLL inhibitor ...
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
